Physician profile
Reza Askari
NPI 1063536944
$4,430.75
in general payments reported to CMS, 2019-2025
7 companies · $433 in 2025
The $433 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.64 · 2020: $13.77 · 2022: $1,288 · 2023: $2,047 · 2024: $605 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,838 · Consulting Fee: $1,000 · Travel and Lodging: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,837.92 |
| Consulting Fee | $1,000.00 |
| Travel and Lodging | $246.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $1,934.22 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $1,684.98 | 2020-2025 | Phasix Mesh |
| La Jolla Pharmaceutical Company | $427.05 | 2023-2025 | Giapreza, Xerava |
| Intuitive Surgical, INC. | $137.59 | 2023 | Da Vinci Surgical System |
| Kci USA, INC. | $118.94 | 2022 | |
| Bioventus LLC | $83.33 | 2025 | Stimrouter Implantable Kit |
| Covidien LP | $44.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reza Askari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.